血液科指南

订阅

MedSci主页 / 所有栏目 / 血液科指南

2021 IMWG共识：基于外周血浆细胞百分比的原发性浆细胞白血病的定义

2021-12-02 国际骨髓瘤工作组 Blood Cancer J

白血病髓系疾病

2021年12月，国际骨髓瘤工作组(IMWG)发布了基于外周血浆细胞百分比的原发性浆细胞白血病的定义共识。

中文标题：

2021 IMWG共识：基于外周血浆细胞百分比的原发性浆细胞白血病的定义

英文标题：

Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage

发布机构：

国际骨髓瘤工作组

发布日期：

2021-12-02

简要介绍：

2021年12月，国际骨髓瘤工作组(IMWG)发布了基于外周血浆细胞百分比的原发性浆细胞白血病的定义共识。原发性浆细胞白血病（PCL）的预后较差，本文主要依据循环浆细胞在符合多发性骨髓瘤诊断标准的患者中的存在情况，重新审查了PCL的诊断。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 IMWG共识：基于外周血浆细胞百分比的原发性浆细胞白血病的定义.pdf)] GetToolGuiderByIdResponse(projectId=1, id=26b811c002285368, title=2021 IMWG共识：基于外周血浆细胞百分比的原发性浆细胞白血病的定义, enTitle=Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage, guiderFrom=Blood Cancer J, authorId=0, author=, summary=2021年12月，国际骨髓瘤工作组(IMWG)发布了基于外周血浆细胞百分比的原发性浆细胞白血病的定义共识。, cover=https://img.medsci.cn/2021127/1638869780193_1608702.png, journalId=0, articlesId=null, associationId=28, associationName=国际骨髓瘤工作组, associationIntro=国际骨髓瘤工作组（International Myeloma Working Group，IMWG ）是国际骨髓瘤基金会成立，旨在为研究者提供一个平台，以便就科研和临床中的重要问题进行合作。 目前工作组中有134名来自世界各地的研究人员。迄今为止，小组工作主要集中在多发性骨髓瘤的治疗和诊断领域。, copyright=0, guiderPublishedTime=Thu Dec 02 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年12月，国际骨髓瘤工作组(IMWG)发布了基于外周血浆细胞百分比的原发性浆细胞白血病的定义共识。原发性浆细胞白血病（PCL）的预后较差，本文主要依据循环浆细胞在符合多发性骨髓瘤诊断标准的患者中的存在情况，重新审查了PCL的诊断。</span></p>, tagList=[TagDto(tagId=809, tagName=白血病), TagDto(tagId=117037, tagName=髓系疾病)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=809, guiderKeyword=白血病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=14363, appHits=79, showAppHits=0, pcHits=613, showPcHits=14284, likes=1, shares=10, comments=5, approvalStatus=1, publishedTime=Tue Dec 07 18:10:14 CST 2021, publishedTimeString=2021-12-02, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Tue Dec 07 17:40:34 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 03:28:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 IMWG共识：基于外周血浆细胞百分比的原发性浆细胞白血病的定义.pdf)])
2021 IMWG共识：基于外周血浆细胞百分比的原发性浆细胞白血病的定义.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1226028, encodeId=60061226028b8, content=非常感谢！😊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Sun Jun 12 20:08:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079496, encodeId=5fb810e949610, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa0b6157897, createdName=ms3000000098940767, createdTime=Mon Dec 13 11:14:15 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078289, encodeId=d5e610e8289a5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 09 06:59:58 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077946, encodeId=6f6210e794631, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 08 06:58:04 CST 2021, time=2021-12-08, status=1, ipAttribution=)]
    2022-06-12 妙医生

    非常感谢！😊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1226028, encodeId=60061226028b8, content=非常感谢！😊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Sun Jun 12 20:08:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079496, encodeId=5fb810e949610, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa0b6157897, createdName=ms3000000098940767, createdTime=Mon Dec 13 11:14:15 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078289, encodeId=d5e610e8289a5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 09 06:59:58 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077946, encodeId=6f6210e794631, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 08 06:58:04 CST 2021, time=2021-12-08, status=1, ipAttribution=)]
    2021-12-13 ms3000000098940767

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1226028, encodeId=60061226028b8, content=非常感谢！😊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Sun Jun 12 20:08:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079496, encodeId=5fb810e949610, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa0b6157897, createdName=ms3000000098940767, createdTime=Mon Dec 13 11:14:15 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078289, encodeId=d5e610e8289a5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 09 06:59:58 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077946, encodeId=6f6210e794631, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 08 06:58:04 CST 2021, time=2021-12-08, status=1, ipAttribution=)]
    2021-12-09 微探

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1226028, encodeId=60061226028b8, content=非常感谢！😊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Sun Jun 12 20:08:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079496, encodeId=5fb810e949610, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa0b6157897, createdName=ms3000000098940767, createdTime=Mon Dec 13 11:14:15 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078289, encodeId=d5e610e8289a5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Dec 09 06:59:58 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077946, encodeId=6f6210e794631, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 08 06:58:04 CST 2021, time=2021-12-08, status=1, ipAttribution=)]
    2021-12-08 微探

    学习学习

    0

相关指南

慢性粒-单核细胞白血病诊断与治疗中国指南（2021年版）

中华医学会血液学分会白血病淋巴瘤学组 · 2021-01-28

2018 中国白血病异基因造血干细胞移植后复发的监测，治疗和预防共识（英文版）

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2018-09-11

中国蒽环类药物在白血病治疗中的临床应用专家共识

中国抗癌协会肿瘤临床化疗专业委员会 · 2018-03-20

复发难治性急性髓系白血病中国诊疗指南（2017年版）

中华医学会血液学分会白血病淋巴瘤学组 · 2017-03-30

2015 第6届欧洲白血病感染会议（ECIL）指南：异基因造血干细胞移植后爱泼斯坦-巴尔病毒感染和移植后淋巴组织增生性疾病的管理

欧洲白血病感染会议(ECIL,European Conference on Infections in Leukaemia) · 2015-09-11

中国慢性淋巴细胞白血病／小淋巴细胞淋巴瘤的诊断与治疗指南(2015年版)

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2015-11-18

拓展阅读

2009 ELN 成人急性髓系白血病的诊断和治疗

欧洲白血病网(ELN,European LeukmiaNet) · 2009-10-30

成人急性髓系白血病(AML)诊断、治疗及随访的最低临床建议（2010）

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-01-01

中国慢性淋巴细胞白血病诊断与治疗专家共识（2010）

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2010-02-01

2010 慢性髓性白血病治疗专家共识

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2010-03-01

急性髓系白血病（2010）

美国癌症学会(ACS,American Cancer Society) · 2010-10-12

中国慢性髓系白血病诊断与治疗指南（2011年版）

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2011-06-01